nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—Hypoxia—Gemcitabine—kidney cancer	0.0202	0.0202	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Temsirolimus—kidney cancer	0.0198	0.0198	CcSEcCtD
Butabarbital—Hepatocellular injury—Everolimus—kidney cancer	0.0192	0.0192	CcSEcCtD
Butabarbital—Hepatocellular injury—Erlotinib—kidney cancer	0.0185	0.0185	CcSEcCtD
Butabarbital—Respiratory failure—Sunitinib—kidney cancer	0.0163	0.0163	CcSEcCtD
Butabarbital—Depressed level of consciousness—Sunitinib—kidney cancer	0.0155	0.0155	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Everolimus—kidney cancer	0.0147	0.0147	CcSEcCtD
Butabarbital—Respiratory failure—Vincristine—kidney cancer	0.0138	0.0138	CcSEcCtD
Butabarbital—Respiratory failure—Gemcitabine—kidney cancer	0.0131	0.0131	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Sorafenib—kidney cancer	0.0128	0.0128	CcSEcCtD
Butabarbital—Bradycardia—Pazopanib—kidney cancer	0.0124	0.0124	CcSEcCtD
Butabarbital—Respiratory failure—Paclitaxel—kidney cancer	0.011	0.011	CcSEcCtD
Butabarbital—Angioedema—Temsirolimus—kidney cancer	0.0103	0.0103	CcSEcCtD
Butabarbital—Hallucination—Everolimus—kidney cancer	0.00958	0.00958	CcSEcCtD
Butabarbital—Anxiety—Temsirolimus—kidney cancer	0.00956	0.00956	CcSEcCtD
Butabarbital—Syncope—Pazopanib—kidney cancer	0.00952	0.00952	CcSEcCtD
Butabarbital—Loss of consciousness—Pazopanib—kidney cancer	0.00933	0.00933	CcSEcCtD
Butabarbital—Ataxia—Vincristine—kidney cancer	0.00924	0.00924	CcSEcCtD
Butabarbital—Depressed level of consciousness—Capecitabine—kidney cancer	0.00852	0.00852	CcSEcCtD
Butabarbital—Shock—Pazopanib—kidney cancer	0.00852	0.00852	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.00828	0.00828	CcSEcCtD
Butabarbital—Bradycardia—Sunitinib—kidney cancer	0.00819	0.00819	CcSEcCtD
Butabarbital—Somnolence—Temsirolimus—kidney cancer	0.00817	0.00817	CcSEcCtD
Butabarbital—Constipation—Temsirolimus—kidney cancer	0.00786	0.00786	CcSEcCtD
Butabarbital—Agitation—Everolimus—kidney cancer	0.0077	0.0077	CcSEcCtD
Butabarbital—Somnolence—Pazopanib—kidney cancer	0.0077	0.0077	CcSEcCtD
Butabarbital—Angioedema—Everolimus—kidney cancer	0.00766	0.00766	CcSEcCtD
Butabarbital—Syncope—Everolimus—kidney cancer	0.00752	0.00752	CcSEcCtD
Butabarbital—Loss of consciousness—Everolimus—kidney cancer	0.00737	0.00737	CcSEcCtD
Butabarbital—Ataxia—Paclitaxel—kidney cancer	0.00734	0.00734	CcSEcCtD
Butabarbital—Body temperature increased—Temsirolimus—kidney cancer	0.00727	0.00727	CcSEcCtD
Butabarbital—Syncope—Erlotinib—kidney cancer	0.00725	0.00725	CcSEcCtD
Butabarbital—Anxiety—Everolimus—kidney cancer	0.00711	0.00711	CcSEcCtD
Butabarbital—Loss of consciousness—Erlotinib—kidney cancer	0.00711	0.00711	CcSEcCtD
Butabarbital—Anxiety—Erlotinib—kidney cancer	0.00686	0.00686	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00679	0.00679	CcSEcCtD
Butabarbital—Hypersensitivity—Temsirolimus—kidney cancer	0.00677	0.00677	CcSEcCtD
Butabarbital—Hallucination—Vincristine—kidney cancer	0.00677	0.00677	CcSEcCtD
Butabarbital—Liver injury—Doxorubicin—kidney cancer	0.00676	0.00676	CcSEcCtD
Butabarbital—Shock—Everolimus—kidney cancer	0.00673	0.00673	CcSEcCtD
Butabarbital—Angioedema—Sorafenib—kidney cancer	0.00665	0.00665	CcSEcCtD
Butabarbital—Syncope—Sorafenib—kidney cancer	0.00652	0.00652	CcSEcCtD
Butabarbital—Shock—Erlotinib—kidney cancer	0.00649	0.00649	CcSEcCtD
Butabarbital—Angioedema—Sunitinib—kidney cancer	0.0064	0.0064	CcSEcCtD
Butabarbital—Loss of consciousness—Sorafenib—kidney cancer	0.00639	0.00639	CcSEcCtD
Butabarbital—Hypotension—Everolimus—kidney cancer	0.00639	0.00639	CcSEcCtD
Butabarbital—Somnolence—Everolimus—kidney cancer	0.00608	0.00608	CcSEcCtD
Butabarbital—Dizziness—Temsirolimus—kidney cancer	0.00608	0.00608	CcSEcCtD
Butabarbital—Ataxia—Capecitabine—kidney cancer	0.00603	0.00603	CcSEcCtD
Butabarbital—Constipation—Vinblastine—kidney cancer	0.00587	0.00587	CcSEcCtD
Butabarbital—Constipation—Everolimus—kidney cancer	0.00585	0.00585	CcSEcCtD
Butabarbital—Vomiting—Temsirolimus—kidney cancer	0.00585	0.00585	CcSEcCtD
Butabarbital—Shock—Sorafenib—kidney cancer	0.00584	0.00584	CcSEcCtD
Butabarbital—Rash—Temsirolimus—kidney cancer	0.0058	0.0058	CcSEcCtD
Butabarbital—Dermatitis—Temsirolimus—kidney cancer	0.00579	0.00579	CcSEcCtD
Butabarbital—Headache—Temsirolimus—kidney cancer	0.00576	0.00576	CcSEcCtD
Butabarbital—Dizziness—Pazopanib—kidney cancer	0.00573	0.00573	CcSEcCtD
Butabarbital—Hepatocellular injury—Doxorubicin—kidney cancer	0.00569	0.00569	CcSEcCtD
Butabarbital—Feeling abnormal—Vinblastine—kidney cancer	0.00566	0.00566	CcSEcCtD
Butabarbital—Constipation—Erlotinib—kidney cancer	0.00564	0.00564	CcSEcCtD
Butabarbital—Feeling abnormal—Everolimus—kidney cancer	0.00564	0.00564	CcSEcCtD
Butabarbital—Shock—Sunitinib—kidney cancer	0.00562	0.00562	CcSEcCtD
Butabarbital—Vomiting—Pazopanib—kidney cancer	0.00551	0.00551	CcSEcCtD
Butabarbital—Bradycardia—Paclitaxel—kidney cancer	0.0055	0.0055	CcSEcCtD
Butabarbital—Rash—Pazopanib—kidney cancer	0.00546	0.00546	CcSEcCtD
Butabarbital—Nausea—Temsirolimus—kidney cancer	0.00546	0.00546	CcSEcCtD
Butabarbital—Dermatitis—Pazopanib—kidney cancer	0.00546	0.00546	CcSEcCtD
Butabarbital—Agitation—Vincristine—kidney cancer	0.00544	0.00544	CcSEcCtD
Butabarbital—Headache—Pazopanib—kidney cancer	0.00543	0.00543	CcSEcCtD
Butabarbital—Body temperature increased—Everolimus—kidney cancer	0.00541	0.00541	CcSEcCtD
Butabarbital—Body temperature increased—Erlotinib—kidney cancer	0.00522	0.00522	CcSEcCtD
Butabarbital—Nausea—Pazopanib—kidney cancer	0.00515	0.00515	CcSEcCtD
Butabarbital—Constipation—Sorafenib—kidney cancer	0.00508	0.00508	CcSEcCtD
Butabarbital—Hypersensitivity—Vinblastine—kidney cancer	0.00506	0.00506	CcSEcCtD
Butabarbital—Hypersensitivity—Everolimus—kidney cancer	0.00504	0.00504	CcSEcCtD
Butabarbital—Constipation—Sunitinib—kidney cancer	0.00489	0.00489	CcSEcCtD
Butabarbital—Body temperature increased—Sorafenib—kidney cancer	0.00469	0.00469	CcSEcCtD
Butabarbital—Tension—Paclitaxel—kidney cancer	0.00461	0.00461	CcSEcCtD
Butabarbital—Nervousness—Paclitaxel—kidney cancer	0.00457	0.00457	CcSEcCtD
Butabarbital—Dizziness—Vinblastine—kidney cancer	0.00454	0.00454	CcSEcCtD
Butabarbital—Dizziness—Everolimus—kidney cancer	0.00452	0.00452	CcSEcCtD
Butabarbital—Body temperature increased—Sunitinib—kidney cancer	0.00452	0.00452	CcSEcCtD
Butabarbital—Hypotension—Vincristine—kidney cancer	0.00452	0.00452	CcSEcCtD
Butabarbital—Bradycardia—Capecitabine—kidney cancer	0.00451	0.00451	CcSEcCtD
Butabarbital—Feeling abnormal—Dactinomycin—kidney cancer	0.00446	0.00446	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00438	0.00438	CcSEcCtD
Butabarbital—Hypersensitivity—Sorafenib—kidney cancer	0.00437	0.00437	CcSEcCtD
Butabarbital—Vomiting—Vinblastine—kidney cancer	0.00437	0.00437	CcSEcCtD
Butabarbital—Dizziness—Erlotinib—kidney cancer	0.00436	0.00436	CcSEcCtD
Butabarbital—Vomiting—Everolimus—kidney cancer	0.00435	0.00435	CcSEcCtD
Butabarbital—Agitation—Paclitaxel—kidney cancer	0.00432	0.00432	CcSEcCtD
Butabarbital—Rash—Everolimus—kidney cancer	0.00431	0.00431	CcSEcCtD
Butabarbital—Dermatitis—Everolimus—kidney cancer	0.00431	0.00431	CcSEcCtD
Butabarbital—Headache—Vinblastine—kidney cancer	0.0043	0.0043	CcSEcCtD
Butabarbital—Angioedema—Paclitaxel—kidney cancer	0.0043	0.0043	CcSEcCtD
Butabarbital—Headache—Everolimus—kidney cancer	0.00428	0.00428	CcSEcCtD
Butabarbital—Hypotension—Gemcitabine—kidney cancer	0.00428	0.00428	CcSEcCtD
Butabarbital—Body temperature increased—Dactinomycin—kidney cancer	0.00428	0.00428	CcSEcCtD
Butabarbital—Syncope—Paclitaxel—kidney cancer	0.00422	0.00422	CcSEcCtD
Butabarbital—Hypersensitivity—Sunitinib—kidney cancer	0.00421	0.00421	CcSEcCtD
Butabarbital—Vomiting—Erlotinib—kidney cancer	0.0042	0.0042	CcSEcCtD
Butabarbital—Rash—Erlotinib—kidney cancer	0.00416	0.00416	CcSEcCtD
Butabarbital—Dermatitis—Erlotinib—kidney cancer	0.00416	0.00416	CcSEcCtD
Butabarbital—Headache—Erlotinib—kidney cancer	0.00413	0.00413	CcSEcCtD
Butabarbital—Loss of consciousness—Paclitaxel—kidney cancer	0.00413	0.00413	CcSEcCtD
Butabarbital—Constipation—Vincristine—kidney cancer	0.00413	0.00413	CcSEcCtD
Butabarbital—Nausea—Vinblastine—kidney cancer	0.00408	0.00408	CcSEcCtD
Butabarbital—Somnolence—Gemcitabine—kidney cancer	0.00408	0.00408	CcSEcCtD
Butabarbital—Nausea—Everolimus—kidney cancer	0.00406	0.00406	CcSEcCtD
Butabarbital—Anxiety—Paclitaxel—kidney cancer	0.00399	0.00399	CcSEcCtD
Butabarbital—Hypersensitivity—Dactinomycin—kidney cancer	0.00398	0.00398	CcSEcCtD
Butabarbital—Dizziness—Sorafenib—kidney cancer	0.00393	0.00393	CcSEcCtD
Butabarbital—Constipation—Gemcitabine—kidney cancer	0.00392	0.00392	CcSEcCtD
Butabarbital—Nausea—Erlotinib—kidney cancer	0.00392	0.00392	CcSEcCtD
Butabarbital—Ataxia—Doxorubicin—kidney cancer	0.00388	0.00388	CcSEcCtD
Butabarbital—Confusional state—Paclitaxel—kidney cancer	0.00387	0.00387	CcSEcCtD
Butabarbital—Body temperature increased—Vincristine—kidney cancer	0.00382	0.00382	CcSEcCtD
Butabarbital—Dizziness—Sunitinib—kidney cancer	0.00378	0.00378	CcSEcCtD
Butabarbital—Feeling abnormal—Gemcitabine—kidney cancer	0.00378	0.00378	CcSEcCtD
Butabarbital—Shock—Paclitaxel—kidney cancer	0.00378	0.00378	CcSEcCtD
Butabarbital—Vomiting—Sorafenib—kidney cancer	0.00377	0.00377	CcSEcCtD
Butabarbital—Rash—Sorafenib—kidney cancer	0.00374	0.00374	CcSEcCtD
Butabarbital—Dermatitis—Sorafenib—kidney cancer	0.00374	0.00374	CcSEcCtD
Butabarbital—Headache—Sorafenib—kidney cancer	0.00372	0.00372	CcSEcCtD
Butabarbital—Vomiting—Sunitinib—kidney cancer	0.00363	0.00363	CcSEcCtD
Butabarbital—Body temperature increased—Gemcitabine—kidney cancer	0.00362	0.00362	CcSEcCtD
Butabarbital—Rash—Sunitinib—kidney cancer	0.0036	0.0036	CcSEcCtD
Butabarbital—Dermatitis—Sunitinib—kidney cancer	0.0036	0.0036	CcSEcCtD
Butabarbital—Hypotension—Paclitaxel—kidney cancer	0.00359	0.00359	CcSEcCtD
Butabarbital—Headache—Sunitinib—kidney cancer	0.00358	0.00358	CcSEcCtD
Butabarbital—Hypersensitivity—Vincristine—kidney cancer	0.00356	0.00356	CcSEcCtD
Butabarbital—Nausea—Sorafenib—kidney cancer	0.00353	0.00353	CcSEcCtD
Butabarbital—Syncope—Capecitabine—kidney cancer	0.00346	0.00346	CcSEcCtD
Butabarbital—Vomiting—Dactinomycin—kidney cancer	0.00344	0.00344	CcSEcCtD
Butabarbital—Somnolence—Paclitaxel—kidney cancer	0.00341	0.00341	CcSEcCtD
Butabarbital—Rash—Dactinomycin—kidney cancer	0.00341	0.00341	CcSEcCtD
Butabarbital—Nausea—Sunitinib—kidney cancer	0.00339	0.00339	CcSEcCtD
Butabarbital—Loss of consciousness—Capecitabine—kidney cancer	0.00339	0.00339	CcSEcCtD
Butabarbital—Constipation—Paclitaxel—kidney cancer	0.00328	0.00328	CcSEcCtD
Butabarbital—Anxiety—Capecitabine—kidney cancer	0.00327	0.00327	CcSEcCtD
Butabarbital—Nausea—Dactinomycin—kidney cancer	0.00321	0.00321	CcSEcCtD
Butabarbital—Dizziness—Vincristine—kidney cancer	0.0032	0.0032	CcSEcCtD
Butabarbital—Confusional state—Capecitabine—kidney cancer	0.00318	0.00318	CcSEcCtD
Butabarbital—Feeling abnormal—Paclitaxel—kidney cancer	0.00316	0.00316	CcSEcCtD
Butabarbital—Shock—Capecitabine—kidney cancer	0.0031	0.0031	CcSEcCtD
Butabarbital—Vomiting—Vincristine—kidney cancer	0.00307	0.00307	CcSEcCtD
Butabarbital—Rash—Vincristine—kidney cancer	0.00305	0.00305	CcSEcCtD
Butabarbital—Dermatitis—Vincristine—kidney cancer	0.00304	0.00304	CcSEcCtD
Butabarbital—Body temperature increased—Paclitaxel—kidney cancer	0.00303	0.00303	CcSEcCtD
Butabarbital—Headache—Vincristine—kidney cancer	0.00303	0.00303	CcSEcCtD
Butabarbital—Hypotension—Capecitabine—kidney cancer	0.00294	0.00294	CcSEcCtD
Butabarbital—Vomiting—Gemcitabine—kidney cancer	0.00291	0.00291	CcSEcCtD
Butabarbital—Bradycardia—Doxorubicin—kidney cancer	0.00291	0.00291	CcSEcCtD
Butabarbital—Rash—Gemcitabine—kidney cancer	0.00289	0.00289	CcSEcCtD
Butabarbital—Dermatitis—Gemcitabine—kidney cancer	0.00289	0.00289	CcSEcCtD
Butabarbital—Headache—Gemcitabine—kidney cancer	0.00287	0.00287	CcSEcCtD
Butabarbital—Nausea—Vincristine—kidney cancer	0.00287	0.00287	CcSEcCtD
Butabarbital—Hypersensitivity—Paclitaxel—kidney cancer	0.00283	0.00283	CcSEcCtD
Butabarbital—Nausea—Gemcitabine—kidney cancer	0.00272	0.00272	CcSEcCtD
Butabarbital—Constipation—Capecitabine—kidney cancer	0.00269	0.00269	CcSEcCtD
Butabarbital—Feeling abnormal—Capecitabine—kidney cancer	0.0026	0.0026	CcSEcCtD
Butabarbital—Dizziness—Paclitaxel—kidney cancer	0.00254	0.00254	CcSEcCtD
Butabarbital—Body temperature increased—Capecitabine—kidney cancer	0.00249	0.00249	CcSEcCtD
Butabarbital—Tension—Doxorubicin—kidney cancer	0.00244	0.00244	CcSEcCtD
Butabarbital—Vomiting—Paclitaxel—kidney cancer	0.00244	0.00244	CcSEcCtD
Butabarbital—Rash—Paclitaxel—kidney cancer	0.00242	0.00242	CcSEcCtD
Butabarbital—Dermatitis—Paclitaxel—kidney cancer	0.00242	0.00242	CcSEcCtD
Butabarbital—Nervousness—Doxorubicin—kidney cancer	0.00242	0.00242	CcSEcCtD
Butabarbital—Headache—Paclitaxel—kidney cancer	0.0024	0.0024	CcSEcCtD
Butabarbital—Hypersensitivity—Capecitabine—kidney cancer	0.00232	0.00232	CcSEcCtD
Butabarbital—Agitation—Doxorubicin—kidney cancer	0.00229	0.00229	CcSEcCtD
Butabarbital—Nausea—Paclitaxel—kidney cancer	0.00228	0.00228	CcSEcCtD
Butabarbital—Syncope—Doxorubicin—kidney cancer	0.00223	0.00223	CcSEcCtD
Butabarbital—Loss of consciousness—Doxorubicin—kidney cancer	0.00219	0.00219	CcSEcCtD
Butabarbital—Anxiety—Doxorubicin—kidney cancer	0.00211	0.00211	CcSEcCtD
Butabarbital—Dizziness—Capecitabine—kidney cancer	0.00208	0.00208	CcSEcCtD
Butabarbital—Confusional state—Doxorubicin—kidney cancer	0.00205	0.00205	CcSEcCtD
Butabarbital—Vomiting—Capecitabine—kidney cancer	0.002	0.002	CcSEcCtD
Butabarbital—Shock—Doxorubicin—kidney cancer	0.002	0.002	CcSEcCtD
Butabarbital—Rash—Capecitabine—kidney cancer	0.00199	0.00199	CcSEcCtD
Butabarbital—Dermatitis—Capecitabine—kidney cancer	0.00198	0.00198	CcSEcCtD
Butabarbital—Headache—Capecitabine—kidney cancer	0.00197	0.00197	CcSEcCtD
Butabarbital—Hypotension—Doxorubicin—kidney cancer	0.0019	0.0019	CcSEcCtD
Butabarbital—Nausea—Capecitabine—kidney cancer	0.00187	0.00187	CcSEcCtD
Butabarbital—Somnolence—Doxorubicin—kidney cancer	0.0018	0.0018	CcSEcCtD
Butabarbital—Constipation—Doxorubicin—kidney cancer	0.00174	0.00174	CcSEcCtD
Butabarbital—Feeling abnormal—Doxorubicin—kidney cancer	0.00167	0.00167	CcSEcCtD
Butabarbital—Body temperature increased—Doxorubicin—kidney cancer	0.0016	0.0016	CcSEcCtD
Butabarbital—Hypersensitivity—Doxorubicin—kidney cancer	0.0015	0.0015	CcSEcCtD
Butabarbital—Dizziness—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Butabarbital—Vomiting—Doxorubicin—kidney cancer	0.00129	0.00129	CcSEcCtD
Butabarbital—Rash—Doxorubicin—kidney cancer	0.00128	0.00128	CcSEcCtD
Butabarbital—Dermatitis—Doxorubicin—kidney cancer	0.00128	0.00128	CcSEcCtD
Butabarbital—Headache—Doxorubicin—kidney cancer	0.00127	0.00127	CcSEcCtD
Butabarbital—Nausea—Doxorubicin—kidney cancer	0.00121	0.00121	CcSEcCtD
